Milena S. Espíndola

960 total citations
31 papers, 625 citations indexed

About

Milena S. Espíndola is a scholar working on Pulmonary and Respiratory Medicine, Immunology and Virology. According to data from OpenAlex, Milena S. Espíndola has authored 31 papers receiving a total of 625 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Pulmonary and Respiratory Medicine, 8 papers in Immunology and 7 papers in Virology. Recurrent topics in Milena S. Espíndola's work include Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), HIV Research and Treatment (6 papers) and HIV-related health complications and treatments (4 papers). Milena S. Espíndola is often cited by papers focused on Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (14 papers), HIV Research and Treatment (6 papers) and HIV-related health complications and treatments (4 papers). Milena S. Espíndola collaborates with scholars based in United States, Brazil and Australia. Milena S. Espíndola's co-authors include Cory M. Hogaboam, David M. Habiel, Ana Lúcia Coelho, Fabiani Gai Frantz, Fabiana Albani Zambuzi, Barry R. Stripp, Leonardo J. Galvão-Lima, Maira da Costa Cacemiro, Verônica S. Brauer and Valdes Roberto Bóllela and has published in prestigious journals such as Cell, PLoS ONE and American Journal of Respiratory and Critical Care Medicine.

In The Last Decade

Milena S. Espíndola

29 papers receiving 621 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Milena S. Espíndola United States	16	270	168	149	95	94	31	625
Jennifer Canniff United States	13	226 0.8×	84 0.5×	183 1.2×	231 2.4×	77 0.8×	27	837
Diane Gosselin Canada	15	281 1.0×	268 1.6×	364 2.4×	112 1.2×	104 1.1×	24	1.0k
Amanda Goodsell United States	11	89 0.3×	104 0.6×	315 2.1×	289 3.0×	102 1.1×	19	688
Karen L. Wood United States	13	273 1.0×	54 0.3×	111 0.7×	228 2.4×	188 2.0×	22	652
Jean‐Paul Coutelier Belgium	15	110 0.4×	98 0.6×	392 2.6×	116 1.2×	101 1.1×	40	717
John C. Lam Canada	13	181 0.7×	220 1.3×	38 0.3×	92 1.0×	114 1.2×	38	574
Anne B. Warwick United States	12	147 0.5×	178 1.1×	86 0.6×	143 1.5×	146 1.6×	33	657
Joshua Fink Australia	8	64 0.2×	124 0.7×	198 1.3×	131 1.4×	332 3.5×	10	834
Jennifer F. A. Swisher United States	7	55 0.2×	220 1.3×	246 1.7×	61 0.6×	39 0.4×	7	560
Vincent Sinickas Australia	10	267 1.0×	190 1.1×	460 3.1×	164 1.7×	62 0.7×	20	1.0k

Countries citing papers authored by Milena S. Espíndola

Since Specialization

Citations

This map shows the geographic impact of Milena S. Espíndola's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Milena S. Espíndola with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Milena S. Espíndola more than expected).

Fields of papers citing papers by Milena S. Espíndola

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Milena S. Espíndola. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Milena S. Espíndola. The network helps show where Milena S. Espíndola may publish in the future.

Co-authorship network of co-authors of Milena S. Espíndola

This figure shows the co-authorship network connecting the top 25 collaborators of Milena S. Espíndola. A scholar is included among the top collaborators of Milena S. Espíndola based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Milena S. Espíndola. Milena S. Espíndola is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

MacKenzie, BreAnne, Poornima Mahavadi, Ana Lúcia Coelho, et al.. (2025). LTI-03 peptide demonstrates anti-fibrotic activity in ex vivo lung slices from patients with IPF. iScience. 28(9). 113437–113437.

Kamiya, Mari, Milena S. Espíndola, Tracy J. Doyle, et al.. (2024). Immune mechanisms in fibrotic interstitial lung disease. Cell. 187(14). 3506–3530. 31 indexed citations

Espíndola, Milena S., David M. Habiel, Ana Lúcia Coelho, et al.. (2023). Translational Studies Reveal the Divergent Effects of Simtuzumab Targeting LOXL2 in Idiopathic Pulmonary Fibrosis. PubMed. 1(2). 10007–10007. 3 indexed citations

Huang, Yong, Shwu‐Fan Ma, Catherine A. Bonham, et al.. (2023). Central lung gene expression associates with myofibroblast features in idiopathic pulmonary fibrosis. BMJ Open Respiratory Research. 10(1). e001391–e001391. 9 indexed citations

Parimon, Tanyalak, et al.. (2022). Potential mechanisms for lung fibrosis associated with COVID-19 infection. QJM. 116(7). 487–492. 16 indexed citations

Espíndola, Milena S., David M. Habiel, Ana Lúcia Coelho, et al.. (2020). Differential Responses to Targeting Matrix Metalloproteinase 9 in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 203(4). 458–470. 38 indexed citations

Espíndola, Milena S., Fabiana Albani Zambuzi, Leonardo J. Galvão-Lima, et al.. (2020). Immunosenescence in chronic HIV infected patients impairs essential functions of their natural killer cells. International Immunopharmacology. 84. 106568–106568. 9 indexed citations

Espíndola, Milena S., Ana Lúcia Coelho, David M. Habiel, et al.. (2019). Targeting MAP3K19 prevents human lung myofibroblast activation both in vitro and in a humanized SCID model of idiopathic pulmonary fibrosis. Scientific Reports. 9(1). 19796–19796. 12 indexed citations

Espíndola, Milena S., David M. Habiel, Ana Lúcia Coelho, et al.. (2018). Targeting of TAM Receptors Ameliorates Fibrotic Mechanisms in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 197(11). 1443–1456. 68 indexed citations

10.

Habiel, David M., Milena S. Espíndola, Ana Lúcia Coelho, & Cory M. Hogaboam. (2018). Modeling Idiopathic Pulmonary Fibrosis in Humanized Severe Combined Immunodeficient Mice. American Journal Of Pathology. 188(4). 891–903. 22 indexed citations

11.

Souza, Camila Oliveira Silva, Milena S. Espíndola, Caroline Fontanari, et al.. (2018). CD18 Regulates Monocyte Hematopoiesis and Promotes Resistance to Experimental Schistosomiasis. Frontiers in Immunology. 9. 1970–1970. 15 indexed citations

12.

Habiel, David M., Milena S. Espíndola, Chris Kitson, et al.. (2018). Characterization of CD28null T cells in idiopathic pulmonary fibrosis. Mucosal Immunology. 12(1). 212–222. 40 indexed citations

13.

Huang, Yong, Shwu‐Fan Ma, Milena S. Espíndola, et al.. (2017). Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis. American Journal of Respiratory and Critical Care Medicine. 196(2). 208–219. 95 indexed citations

14.

Habiel, David M., Ana Camelo, Milena S. Espíndola, et al.. (2017). Divergent roles for Clusterin in Lung Injury and Repair. Scientific Reports. 7(1). 15444–15444. 28 indexed citations

15.

Espíndola, Milena S., Caroline Fontanari, Rogério Silva Rosada, et al.. (2016). 5-lipoxygenase pathway is essential for the control of granuloma extension induced by Schistosoma mansoni eggs in lung. Experimental Parasitology. 167. 124–129. 7 indexed citations

16.

Zambuzi, Fabiana Albani, Milena S. Espíndola, Leonardo J. Galvão-Lima, et al.. (2016). Identification of promising plasma immune biomarkers to differentiate active pulmonary tuberculosis. Cytokine. 88. 99–107. 30 indexed citations

17.

Espíndola, Milena S., Leonardo J. Galvão-Lima, Fabiana Albani Zambuzi, et al.. (2016). HIV infection: focus on the innate immune cells. Immunologic Research. 64(5-6). 1118–1132. 30 indexed citations

18.

Sartim, Marco Aurélio, Tássia R. Costa, Hélen Julie Laure, et al.. (2015). Moojenactivase, a novel pro-coagulant PIIId metalloprotease isolated from Bothrops moojeni snake venom, activates coagulation factors II and X and induces tissue factor up-regulation in leukocytes. Archives of Toxicology. 90(5). 1261–1278. 27 indexed citations

19.

Assis, Patrícia A., Milena S. Espíndola, Francisco Wanderley Garcia Paula‐Silva, et al.. (2014). Mycobacterium tuberculosis expressing phospholipase C subverts PGE2 synthesis and induces necrosis in alveolar macrophages. BMC Microbiology. 14(1). 128–128. 29 indexed citations

20.

Espíndola, Milena S., Fabiani Gai Frantz, Ana Paula Masson, et al.. (2014). Combined immunization using DNA-Sm14 and DNA-Hsp65 increases CD8+ memory T cells, reduces chronic pathology and decreases egg viability during Schistosoma mansoniinfection. BMC Infectious Diseases. 14(1). 263–263. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact